Chander Sehgal is currently the Director, Market Access at Teva Canada Innovation. In his current role, Chander leads the Market Access strategy and execution, specialty products including Biosimilars. Previously, Chander has worked at the Innovative Medicines Canada, CADTH, GSK Canada, Merck Canada, Pfizer Canada across a variety of roles. Chander is an Oncologist by training, an MBA from the Ivey Business School, University of Western Ontario, Canada, and has a Health Economics diploma from the University of York, UK. Chander is passionate about promoting overall well-being, and is a certified Yoga and Meditation teacher and a marathoner.
Agenda: Day 1 Oct 5, 2020
Agenda: Day 2 Oct 6, 2020
